Large Cap Biotech
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Trend Stats
1-Month Return
-1.43%
3-Month Return
+5.53%
12-Month Return
+32.45%
Volatility Score
2.2
RSI
41.9
ST Trend
Down
LT Trend
Up
Short-Term Trend
Down
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Large Cap Biotech
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | $223B | +44.39% | +15.20% | +9.41% | 2.4 | Neutral | Up |
| GILD | Gilead Sciences | $183B | +27.93% | +13.21% | +3.50% | 2.4 | Neutral | Up |
| VRTX | Vertex Pharma | $123B | +17.71% | +1.03% | -5.86% | 2.4 | Down | Neutral |
| MRNA | MODERNA | $86B | +723.81% | +222.71% | +50.20% | 7.0 | Up | Up |
| REGN | Regeneron Pharma | $78B | +32.20% | +13.71% | -3.63% | 2.7 | Down | Neutral |
| NTRA | Natera | $57B | +128.95% | +44.99% | +20.29% | 4.2 | Up | Up |
| ARGX | arGEN-X SpADR | $50B | -1.27% | -8.40% | -18.46% | 3.4 | Down | Down |
| ILMN | Illumina | $41B | +197.99% | +42.69% | +31.35% | 5.5 | Up | Up |
| RVMD | REVOLUTION MEDIC | $40B | +296.72% | +2.44% | -7.52% | 4.5 | Down | Up |
| ONC | BeOne Medi Sp ADR | $39B | +8.77% | +14.84% | +0.74% | 2.7 | Down | Up |
| BIIB | Biogen | $34B | +57.53% | +9.51% | +5.41% | 2.6 | Up | Up |
| ALNY | Alnylam Pharma | $30B | -52.31% | -22.30% | -10.00% | 4.1 | Down | Down |
| ROIV | ROIVANT SCIENCES | $24B | +103.35% | -3.36% | -18.30% | 3.8 | Down | Up |
| UTHR | United Therapeut | $23B | +25.32% | +1.46% | +9.31% | 3.5 | Up | Up |
| GMAB | GENMAB SP ADR | $22B | +11.66% | +26.98% | +12.63% | 3.5 | Up | Up |
| BNTX | BioNTech Sp ADR | $22B | -13.25% | -1.18% | -7.98% | 3.8 | Down | Down |
| INCY | Incyte | $22B | +26.36% | -4.91% | -10.58% | 3.0 | Down | Neutral |
| INSM | Insmed | $21B | -40.02% | -11.32% | -25.21% | 5.1 | Down | Down |
| MEDP | Medpace Holdings | $17B | +17.98% | +15.03% | +3.81% | 3.0 | Neutral | Up |
| EXEL | Exelixis | $15B | +50.62% | +6.19% | +6.04% | 2.9 | Up | Up |
| ASND | ASCENDIS PHARMA BR | $15B | +6.95% | -15.84% | -15.30% | 4.0 | Down | Down |
| CRL | Charles Riv Lab | $14B | +75.76% | +30.15% | +7.46% | 3.8 | Up | Up |
| NBIX | Neurocrine Biosc | $14B | -1.53% | -22.38% | -13.50% | 2.9 | Down | Down |
| HALO | Halozyme Therape | $12B | +64.47% | +44.03% | +2.26% | 3.0 | Neutral | Up |
| TEM | TEMPUS AI-A | $12B | -24.09% | +21.97% | +15.61% | 8.3 | Neutral | Up |
| SMMT | SUMMIT THERAP | $12B | -28.64% | +1.44% | -11.57% | 7.3 | Down | Down |
| BBIO | BRIDGEBIO PHARMA | $12B | +12.04% | -23.81% | -12.62% | 3.9 | Down | Down |
| TECH | Bio-Techne | $11B | +22.98% | +1.68% | +0.50% | 0.2 | Neutral | Up |
| RGEN | Repligen | $11B | +18.21% | +21.08% | +6.20% | 4.9 | Neutral | Up |
| BMRN | Biomarin Pharm | $11B | +3.64% | -8.14% | -17.20% | 2.9 | Down | Down |
| PCVX | VAXCYTE | $11B | +55.89% | +17.13% | +12.33% | 7.0 | Up | Up |
| MDGL | Madrigal Pharmct | $10B | +3.44% | -14.85% | -15.41% | 3.7 | Down | Down |
| IBRX | IMMUNITYBIO | $10B | +290.44% | +25.80% | +23.89% | 6.9 | Up | Up |
| TWST | TWIST BIOSCIENCE | $10B | +395.35% | +67.49% | +18.95% | 10.0 | Up | Up |
| KRYS | KRYSTAL BIOTECH | $9.5B | +70.78% | -11.63% | -7.45% | 3.3 | Down | Up |
| TXG | 10X GENOMICS-A | $9.4B | +522.10% | +71.87% | +4.67% | 9.9 | Up | Up |
| PTGX | Protagonist Ther | $9B | +80.00% | +6.62% | -6.54% | 3.9 | Down | Up |
| KYMR | KYMERA THERAP | $8.9B | +83.11% | -3.37% | -7.20% | 5.1 | Down | Up |
| CYTK | Cytokinetics | $8.6B | +0.97% | -25.07% | -16.47% | 3.5 | Down | Down |
| BRKR | Bruker | $8.6B | +54.51% | -4.64% | +5.25% | 5.8 | Down | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |